Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,64116,660 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Dissecting the Execution Phase of BAK-Mediated Apoptosis in Cancer
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2021 – 2024

PROJECT SUMMARY BCL-2 family proteins are critical regulators of apoptosis and deregulation of their protein interactions contributes to the development and chemoresistance of canc...

$387K
USD
Completed TRAINING, INDIVIDUAL
A DUAL ROLE OF INTEGRIN ALPHA-3 IN BREAST CANCER CNS METASTASIS & CHEMORESISTANCE
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2023

ABSTRACT Integrins serve a multifaceted role in cancer progression by regulating cell migration as well as mediating signaling pathways important in proliferation and chemoresistan...

$353.4K
USD
Completed TRAINING, INDIVIDUAL
Platelet PI3Kbeta regulation of metastasis
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2024

Abstract Metastasis is the primary cause of morbidity and mortality among patients with solid tumors. Platelets interact with tumor cells upon their entry into the vasculature and...

$517.5K
USD
Active NON-SBIR/STTR RPGS
Dynamic µOCT for cellular tissue phenotyping
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

Phenotyping cells and tissue is a critical function that spans basic science to clinical diagnosis. Yet, established methods for phenotyping cells in tissue are static, are evaluat...

$5.97M
USD
Completed NON-SBIR/STTR RPGS
Adoptive Cellular Therapy of T Cell Lymphoma
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2023

PROJECT SUMMARY Peripheral T cell lymphomas (PTCL) are a highly heterogeneous group of neoplasms that account for 10-30% of all Non-Hodgkin Lymphomas. Of these, angioimmunoblastic...

$2.3M
USD
Completed TRAINING, INDIVIDUAL
The Effect of Tumor Burden on Peripheral cDC1 Activation and Functionality
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Tumors disrupt the homeostasis of the immune system, altering immune cell composition and phenotype in the tumor microenvironment (TME), lymph nodes, splee...

$384.5K
USD
Active NON-SBIR/STTR RPGS
Ethnicity and Lung Cancer Survival: A Test of the Hispanic Sociocultural Hypothesis
NATIONAL CANCER INSTITUTE University of Arizona United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT As the leading cause of cancer death, lung cancer represents the most significant cancer-related public health challenge in the United States. Although low...

$6.47M
USD
Active OTHER RESEARCH-RELATED
Defining PARP Inhibitor Response and Resistance in Prostate Cancer
NATIONAL CANCER INSTITUTE University of California At Davis United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The objective of this K01 award is to promote the development of Dr. Alan Lombard into an independent prostate cancer researcher. The proposed project will...

$1.67M
USD
Active NON-SBIR/STTR RPGS
Improving the translational value of head and neck cancer patient-in-mouse models
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Abstract: Patient-derived model systems are commonly used to study tumor biology and test novel treatments for head and neck cancer. These models are established using pati...

$5.29M
USD
Active NON-SBIR/STTR RPGS
Urine based circulating tumor DNA analysis
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2021 – 2026

ABSTRACT Urine is an underappreciated source for systemic circulating tumor DNA in patients with non-genitourinary cancers. Based on recent data suggesting that blood-based HPV DNA...

$4.55M
USD
Completed NON-SBIR/STTR RPGS
Development of a clinically relevant mouse model of ER+ breast cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2024

The purpose of this proposed R21 project is to develop and validate a novel, clinically relevant mouse model for estrogen receptor-positive (ER+) breast cancer. Most human breast c...

$2.23M
USD
Completed OTHER RESEARCH-RELATED
Defining mechanisms of thalidomide analog resistance
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2025

PROJECT SUMMARY Thalidomide and its analogs, lenalidomide and pomalidomide, have revolutionized the treatment of patients with multiple myeloma (MM) and other hematologic malignanc...

$2.67M
USD
Completed NON-SBIR/STTR RPGS
Remote monitoring of cardiac function in childhood cancer survivors
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2024

Abstract Cardiovascular complications are a leading cause of morbidity and mortality in survivors of childhood cancer. These survivors have a greater than four-fold risk of develop...

$1.74M
USD
Active TRAINING, INDIVIDUAL
Decoding the Tissue of Origin of Cellular Damage from Cell-free DNA in Liquid Biopsies
NATIONAL CANCER INSTITUTE Georgetown University United States 2021 – 2026

ABSTRACT Liquid biopsy applications are rapidly emerging as a minimally invasive approach to collect system-wide representative analytes for genomic monitoring of physiologic and d...

$340.5K
USD
Active NON-SBIR/STTR RPGS
The role of the macroenvironment in pancreatic cancer-induced cachexia
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: OVERALL The overall goal of this Program Project is to gain a better understanding of the underlying mechanisms that drive cachexia in cancer patients, especially...

$19.62M
USD
Active NON-SBIR/STTR RPGS
Project 1 – IL-6/STAT3/NF-kB in Adipose-Muscle Crosstalk in the Pancreatic Cancer Macroenvironment
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: PROJECT 1 Cancer cachexia, or progressive weight loss featuring immunodysmetabolism, causes ~1/3 of cancer deaths. Loss of muscle mass reduces performance status,...

Active NON-SBIR/STTR RPGS
Project 2 NF-#B regulation in muscle wasting and pancreatic cancer-induced cachexia
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: PROJECT 2 Cachexia is a debilitating syndrome that results in severe, involuntary weight loss due to the depletion of skeletal muscle and adipose tissues. This syn...

Active NON-SBIR/STTR RPGS
Project 3 – Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: PROJECT 3 PDAC is among the most deadly malignant solid tumors, with approximately 92% of patients succumbing to the disease within five years of diagnosis, and wi...

Active NON-SBIR/STTR RPGS
Core A - Administration
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROEJCT SUMMARY: CORE A The Administrative Core will provide centralized grant administration, data processing and administrative support for the projects. This Core will also serv...

Active NON-SBIR/STTR RPGS
Core B – Human Biospecimen and Advanced Sequencing Core
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: CORE B The goal of this Program is to advance knowledge of pancreatic ductal adenocarcinoma (PDAC), a recalcitrant cancer with one of the highest rates of cachexia...